FDA clears Vital Images CT TAVR planning app

Vital Images, part of the Toshiba Medical Systems Group, has received 510(k) clearance from the FDA for its CT TAVR (transcatheter aortic valve replacement) planning application. The company will showcase its TAVR planning application at the American College of Cardiology (ACC) annual scientific session, March 9-11 in San Francisco.

TAVR procedures are used to replace faulty aortic valves with artificial valves using endovascular techniques on patients who cannot withstand invasive surgeries. Vital's CT TAVR planning application is used in the planning process to visualize and measure vascular anatomy for the evaluation, treatment and follow-up of aortic vascular disorders.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup